Omega Pharma Bulks Up In Italian Supplements Market With Inpha

Now backed by private-equity firm 21 Invest, Omega Pharma is bolstering its Italian nutraceutical portfolio through the acquistion of Inpha and its Normocis brand.

Italy flag (TinoFotografie/Shutterstock.com)

Italy’s Omega Pharma Srl has expanded its dietary supplements offering in its domestic market by acquiring Inpha Nutraceuticals for an undisclosed sum.

Active in the research, development and commercialization of nutraceuticals, Inpha’s portfolio is centered around the cardiology and neurology supplement categories....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Strategy